Table 2.
Marine Organism | Compounds | Activity/Experimental Model | Depth/Site | Concentrations | Ref. |
---|---|---|---|---|---|
Aspergillus fischeri FS452 |
Fiscpropionates A and C | Inhibitory activities against Mycobacterium tuberculosis protein-tyrosine phosphatase B | 3000 m Indian Ocean |
IC50 = 5.1 and 4 μM, respectively |
[46] |
Emericella sp. SCSIO05240 |
Emerixanthones A and C | Antibacterial activity against E. coli, K. pneumoniae, S. aureus, E.faecalis, A. Baumanni, A. hydrophila | 3258 m South China Sea |
Diameters of inhibition zones were 4–6 mm | [47] |
Emericella sp. SCSIO05240 |
Emerixanthone D | Antifungal activity against Fusarium sp., Penicillium sp., Aspergillus niger, Rhizoctonia solani, Fusariumoxy sporium f. sp. niveum, Fusariumoxy sporium f. sp. cucumeris |
3258 m South China Sea |
Diameters of inhibition zones were 3–4 mm | [47] |
Penicillium aculeatum SD-321 | Compound 1 (peniciaculin A) Compounds 2 (peniciaculin B) and 4 (1-hydroxyboivinianin A) Compound 6 (bisabolane) |
Antibacterial activity against: Micrococcus luteus and Vibrio alginolyticus Edwardsiella tarda and Vibrio harveyi Staphyloccocus aureus and Vibrio parahemolyticus |
2038 m South China Sea |
MIC = 1.0 and 2.0 μg/mL, respectively MIC = 8.0 and 4.0 μg/mL, respectively MIC = 0.5 μg/mL |
[48] |
Penicillium aculeatum SD-321 | Compound 1 (peniciaculin A) Compounds 7 and 10 (bisabolanes) |
Antifungal activity against: Alternaria brassicae Gaeumannomyces graminis |
2038 m South China Sea |
MIC = 0.5 μg/mL MIC = 0.5 μg/mL |
[48] |
Penicillium sp. F23-2 |
Penycyclones A–E | Antimicrobial activity against the Gram-positive bacterium Staphylococcus aureus | 5080 m Jiaozhou Bay, Qingdao, China |
MIC = 0.3 to 1.0 μg/mL | [49] |
Spiromastix sp. MCCC3A00308 |
Spiromastilactones A–M | Antiviral activity against influenza virus replication in vitro | 2869 m South Atlantic |
Table 3 in the reference | [50] |
Simplicillium oblavatum EIODSF 020 | Simplicilliumtide J, Verlamelins A and B | Antifungal activity against Aspergillus versicolor and Curvularia australiensis | 4571 m East Indian Ocean |
MIC = 50 μg/mL | [51] |
Simplicillium oblavatum EIODSF 020 | Simplicilliumtide J, Verlamelins A and B | Antiviral activity against HSV-1 | 4571 m East Indian Ocean |
IC50 = 14.0, 16.7 and 15.6 μM/mL, respectively | [51] |
Acremonium sp. | Acremeremophilanes B and E | Inhibitory effects towards LPS-induced NO production in RAW 264.7 | 2869 m South Atlantic Ocean |
EC50 = 8 μM and 15 μM, respectively | [52] |
Eutypella sp. MCCC3A00281 |
Eutyperemophilanes I and J | Inhibitory effects towards LPS-induced NO production in RAW 264.7 | 5610 m South Atlantic Ocean |
IC50 = 8.6 and 13 μM | [53] |
Penicillium chrysogenum SCSIO411001 |
Trans-epoxyamides, chrysamides C | Inhibitory effects on the Interleukin-17 production | 3386 m Indian Ocean |
1 μM for 40.06% of inhibition | [54] |
Myrothecium sp. BZO-L062 |
(−)-1S-myrothecol and (+)-1R-myrothecol | Anti-inflammatory, inhibiting NO formation in LPS-treated macrophage-like cells | 2130 m Yongxing Island |
EC50 = 1.20 and 1.41 μg/mL | [55] |
Aspergillus sp. SCSIOW2 |
Cyclopenol and cyclopenin | Inhibited the LPS-induced formationof nitric oxide and the secretion of IL-6 in RAW 264.7 cells | 2439 m South China Sea |
IC50 = 50–100 μM | [56] |
Penicillium chrysogenum MCCC 3A00292 | Cyclopenol | Inhibition of human Bladder cancer cell line BIU-87 | - | IC50 = 8.34 μM | [57] |
Penicillium spp. and Eurotium sp. | Fructigenine A, cyclopenol, echinulin, flavoglaucin, and viridicatol | Inhibition of protein-tyrosine phosphatase 1B | - Wan Island, Korea |
IC50 = 10.7, 30.0, 29.4, 13.4, and 64.0 μM, respectively | [58] |
Graphostroma sp. MCC3A00421 |
Reticulol | Decrease the rates of degranulation and histamine release in RBL-2H3 cells | 2721 m Atlantic hydrotermal sulfide |
IC50 =13.5 and 13.7 μM | [59] |
Penicillum granulatum MCCC 3A00475 | Spirograterpene A | Antiallergic activity | 2284 m Prydz Bay of Antarctica |
20 μg/mL | [60] |
Penicillium chrysogenum SCSIO 07007 |
Chrysopyrones A and B | Inhibited protein-tyrosine phosphatase-1B (PTP1B) involved in diabetes mellitus | 1000 m Western Atlantic |
IC50 = 9.32 and 27.8 μg/mL, respectively | [61] |
Engyodontium album DFFSCS021 | Engyodontiumone H (Compound 8) and a polyketide (Compound 16) Compounds 8 and the polyketides compounds 15 and 16 |
Cytotoxic activity against human histiocitic lumphoma U937 Antibacterial activity against Escherichia coli and Bacillus subtilis |
3739 m South China Sea |
IC50 = 4.9 and 8.8 μM, respectively MIC ≤ 64 μg/mL |
[62] |
Acrostalagmus luteoalbus SCSIO F457 |
Luteoalbusins A, B | Cytotoxic activity against SF-268, MCF-7, NCI-H460 and HepG2 | 2801 m South China Sea |
IC50 from 0.23 to 1.31 μM | [63] |
Aspergillus versicolor | Oxisterigmatocystin A–C | Cytotoxic activity against A549 and HL-60 | 800 m Pacific Ocean |
Moderate low micromolar cytotoxicity | [64] |
Penicillium sp. MCCC 3A00005 | Brevione I | Cytotoxicity against MCF-7 cells and A549 cells | 5115 m East Pacific |
IC50 = 7.44 μM and 32.5 μM, respectively | [65] |
Penicillium sp. MCCC 3A00005 | Brevione A | Cytotoxicity against MCF-7 cells | 5115 m East Pacific |
IC50 = 28.4 μM | [65] |
Penicillium sp. F00120 | Penicilliumin A | Moderately inhibited the in vitro proliferation of mouse melanoma (B16), human melanoma (A375), and human cervical carcinoma (Hela) cell lines | 1300 m South China Sea |
GI50 = 27.37, 22.88, and 44.05 μg/mL, respectively | [66] |
Penicillium sp. F23-2 | Sorbicillamines A–E | Cytotoxic activity on HeLa, BEL-7402, HEK-293, HCT-116, and P388 cell line | 5080 m Huiquan bay, yellow Sea |
IC50 > 10 μM | [67] |
Abbreviations: EC50 for Half-maximal effective concentration; MIC for minimum inhibitory concentration; IC50 for the concentration (μg/mL) inducing 50% loss of cell viability; GI50 for 50% of maximal inhibition of cell proliferation; MCF7 for breast cancer cell line, SF-268 for human glioblastoma cell line, LPS for lipopolysaccharide; NO for nitric oxide; RAW 264.7 for macrophage cell line; RBL-2H3 for basophilic leukemia cell line; A549 for lung cancer cells; HeLa for cervical cancer cells; BEL-7402 for human papillomavirus-related endocervical adenocarcinoma; HEK-293 for human embryonic kidney; HCT-116 for human colon cancer cells; P388 for murine leukemia cells lines; “-“ means that there is a lack of corresponding information.